Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6676
PUT
Frontdoor
FTDR
$5.96B
| $483K | ﹤0.01% |
+11,100
| New | +$426K |
|
6677
PUT
NovaGold Resources
NG
$3.48B
| $483K | ﹤0.01% |
81,700
-1,100
| -1% | -$4.7K |
|
6678
ProShares UltraShort Consumer Staples
SZK
$8.86M
| $483K | ﹤0.01% |
4,507
+183
| +4% | +$20.2K |
|
6679
PUT
Varonis Systems
VRNS
$5.17B
| $483K | ﹤0.01% |
23,400
-15,900
| -40% | -$342K |
|
6680
Global X Gold Explorers ETF NEW
GOEX
$131M
| $482K | ﹤0.01% |
20,470
+8,414
| +70% | +$173K |
|
6681
Global X DAX Germany ETF
DAX
$237M
| $481K | ﹤0.01% |
18,153
-6,880
| -27% | -$183K |
|
6682
ProShares Ultra Dow30
DDM
$542M
| $481K | ﹤0.01% |
+19,838
| New | +$465K |
|
6683
Liquidia Corp
LQDA
$6.66B
| $481K | ﹤0.01% |
60,181
-51,289
| -46% | -$482K |
|
|
MAG
6684
PUT
DELISTED
MAG Silver
MAG
| $480K | ﹤0.01% |
45,500
-4,200
| -8% | -$42.1K |
|
|
PENG
6685
PUT
Penguin Solutions Inc
PENG
$3.27B
| $480K | ﹤0.01% |
41,800
-196,800
| -82% | -$1.99M |
|
|
PRFT
6686
CALL
DELISTED
Perficient Inc
PRFT
| $480K | ﹤0.01% |
+14,000
| New | +$429K |
|
|
CDK
6687
CALL
DELISTED
CDK Global, Inc.
CDK
| $480K | ﹤0.01% |
9,700
+3,500
| +56% | +$187K |
|
6688
ASE Group
ASX
$103B
| $479K | ﹤0.01% |
121,292
+52,660
| +77% | +$220K |
|
6689
PUT
CONMED
CNMD
$1.51B
| $479K | ﹤0.01% |
+5,600
| New | +$460K |
|
6690
CALL
Energizer
ENR
$1.56B
| $479K | ﹤0.01% |
12,400
-5,400
| -30% | -$242K |
|
6691
CALL
Fate Therapeutics
FATE
$308M
| $479K | ﹤0.01% |
23,600
-11,500
| -33% | -$207K |
|
6692
TTM Technologies
TTMI
$14.7B
| $479K | ﹤0.01% |
46,989
-203,775
| -81% | -$2.26M |
|
|
CARB
6693
CALL
DELISTED
Carbonite Inc
CARB
| $479K | ﹤0.01% |
+18,400
| New | +$449K |
|
6694
CALL
Savara
SVRA
$1.11B
| $478K | ﹤0.01% |
201,700
+178,400
| +766% | +$1.58M |
|
6695
CALL
Global X SuperDividend ETF
SDIV
$1.21B
| $477K | ﹤0.01% |
9,233
-2,234
| -19% | -$117K |
|
|
Y
6696
PUT
DELISTED
Alleghany Corp
Y
| $477K | ﹤0.01% |
700
-100
| -13% | -$66.3K |
|
|
CNY
6697
DELISTED
Market Vectors-Renminbi
CNY
| $477K | ﹤0.01% |
10,838
-843
| -7% | -$37.2K |
|
6698
CALL
Corbus Pharmaceuticals
CRBP
$195M
| $476K | ﹤0.01% |
2,290
+913
| +66% | +$195K |
|
|
CHAD
6699
CALL
DELISTED
Direxion Daily CSI 300 China A Share Bear 1X Shares
CHAD
| $476K | ﹤0.01% |
16,000
-32,700
| -67% | -$990K |
|
|
FIYY
6700
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
| $476K | ﹤0.01% |
4,424
-802
| -15% | -$82.7K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.